Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)

NCT01434849 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Stopped Difficulty with enrolled patients to complete trial.

Conditions

Infantile Hemangioma
Very Low Birth Weight Infants

Interventions

DRUG: topical 0.5% Timolol maleate
DRUG: Control (placebo) group

Sponsor

Alice K. Gong